To validate this finding, we performed EMSA with nuclear extracts from HL60 cells (human promyelocytic leukemia cells) in the presence or absence of a non-biotin-labeled SP1 competitor and antibodies specific for SP1. This evidence concerns the gene SP1 and acute promyelocytic leukemia.